Skip to content

Effects of a nutrient dense infant formula on the growth and tolerance of infants compared to current practice in Spain.

A randomized, controlled, open-label, parallel-arm, multi-centre intervention trial on the effect of a nutrient dense infant formula compared to current practice, on the growth and tolerance of infants in Spain.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON29641
Enrollment
80
Registered
2008-01-30
Start date
2008-02-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

(non-) organic growth failure

Interventions

Duration intervention: 6-12 weeks. Intervention group: a high energy, high protein and nutrient dense, nutritionally complete, ready-to-use feed for infants 0-12 months. Control group: constitutes all

Sponsors

Numico Research B.V.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Infants aged 0 to 9 months; 2. Infants with increased energy requirements and/or fluid restrictions and/or with indication for using high-energy feeds; 3. The infants must be new consumers of oral high-energy feeds; 4. Infants must have an expected requirement for the study product for at least 6 weeks, with an expected study product intake of, on average, at least 50% of their energy intake; 5. Written parental informed consent must be available.

Exclusion criteria

Exclusion criteria: 1. Infants with cow's milk intolerance, major gastrointestinal hepatic or renal dysfunction, or inherited metabolic disorders including galactosaemia are excluded for this study; 2. Investigator's uncertainty about the willingness or ability of the caretaker to comply with the protocol requirements; 3. Participation in any other studies with investigational or marketed products concomitantly or within two weeks prior to entry into this study.

Design outcomes

Primary

MeasureTime frame
Increase in Z-score for length at 6 weeks relative to baseline.

Secondary

MeasureTime frame
Anthropometrics, gastrointestinal tolerance, fecal microbiology and dietary intake.

Contacts

Public ContactMieke Roelofs

Numico Research B.V. PO Box 7005

Mieke.Roelofs@numico-research.nl+31 (0)317 467 884

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)